Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Tag: fargo

Q32 Bio price target lowered to $15 from $16 at Wells Fargo

Wells Fargo Adjusts Price Target for Q32 Bio: A Cautious Outlook Wells Fargo has recently revised its price target for Q32 Bio (QTTB), lowering it...

Diamondback Energy price target lowered to $215 from $219 at Wells Fargo

Diamondback Energy: A Comprehensive Analysis of Recent Developments and Market Outlook Introduction to Diamondback Energy Diamondback Energy, a prominent player in the energy sector, has recently...

Voyager Therapeutics price target lowered to $10 from $12 at Wells Fargo

Wells Fargo Analyst Adjusts Voyager Therapeutics' Price Target: A Comprehensive Analysis Introduction to the Analyst's Move In a recent move, Wells Fargo analyst Yanan Zhu adjusted...

Concentra price target lowered to $25 from $27 at Wells Fargo

Wells Fargo Adjusts Concentra's Price Target: What Investors Need to Know Introduction to Wells Fargo and Concentra Wells Fargo, a leading financial services company, recently made...

Arvinas price target lowered to $26 from $60 at Wells Fargo

Arvinas (ARVN): A Comprehensive Analysis of Recent Developments and Market Outlook Introduction to Arvinas and Its Recent News Arvinas, Inc. (ARVN), a biotechnology company focused on...

Popular Articles